The report covers the present scenario and the growth prospects of the global autoimmune diseases drugs market for 2016-2020. To calculate the market size, the report considers revenue generated from the sales of branded, generic, and off-label drugs used for the treatment of autoimmune diseases.
Autoimmune diseases are immunological disorders that occur when the immune system attacks and destroys healthy tissues in the body rather than foreign bodies, causing significant pain, inflammation, and organ damage. These diseases can affect the nervous system, cardiovascular system, and musculoskeletal system or individual organs, including the skin, lungs, kidneys, glands, and joints.
Complete Report Available at: http://www.reportsweb.com/global-autoimmune-drugs-market-2016-2020
Autoimmune diseases occur due to genetic, infectious, or environmental factors. There are over 80 autoimmune diseases, including AS, IBD (CD and UC), MS, RA, SLE, and PsA. DMARDs, NSAIDs, corticosteroids, analgesics, and immunosuppressants are the major drug classes used to treat autoimmune diseases. The market is divided into Americas, APAC, and EMEA based on geography. Promising pipeline is considered as market driver whereas Loss of patent exclusivity of branded therapies come up as market challenge.
Key questions answered in this report:
– What will the market size be in 2020 and what will the growth rate be?
– What are the key market trends?
– What is driving this market?
– What are the challenges to market growth?
– Who are the Key vendors in this market space?
– What are the market opportunities and threats faced by the key vendors?
– What are the strengths and weaknesses of the key vendors?
Purchase this Report at: http://www.reportsweb.com/buy&RW0001166686/buy/2500
Table of Content:
01: Executive summary
02: Scope of the report
03: Market research methodology
05: Disease overview
06: Pipeline portfolio
07: Market landscape
08: Market segmentation by type of disease
09: Market segmentation by mechanism of action
10: Market segmentation by drug class
11: Market segmentation by type of molecule
12: Market segmentation by ROA
13: Market segmentation by dosage form
14: Geographical segmentation
15: Market drivers
16: Impact of drivers
17: Market challenges
18: Impact of drivers and challenges
19: Market trends
20: Vendor landscape
22: Explore Publisher
Get Sample Report at: http://www.reportsweb.com/inquiry&RW0001166686/sample
Company Name: ReportsWeb
Contact Person: Rajat Sahni
Country: United States